Tempest Therapeutics, Inc. Balance Sheet
TPST|3 years of annual SEC 10-K data (FY2015-FY2017)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 3 fiscal years. All figures from audited SEC 10-K filings.
Tempest Therapeutics, Inc. had $73M in total assets and $64M in shareholders' equity as of FY2017.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.69 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2017 | FY2016 | FY2015 |
|---|---|---|---|
| Cash & Equivalents | $15.7M | $6.4M | $18.1M |
| Current Assets | $68.8M | $116.4M | $129.9M |
| PP&E (Net) | $3.1M | $5.6M | $8.3M |
| Total Assets | $72.9M | $122.5M | $138.6M |
| Current Liabilities | $7.8M | $13.2M | $11.2M |
| Shareholders' Equity | $64.3M | $55.3M | $41.7M |